Engelborghs, Sebastiaan

The kynurenine pathway in major depression: Haplotype analysis of three related functional candidate genes

Claes, S., Myint, A.-M., Domschke, K., Del-Favero, J., Entrich, K., Engelborghs, S., De Deyn, P., Mueller, N., Baune, B., & Rothermundt, M. (2011) · Psychiatry Research

Tryptophan and brain disordersTreatment of Major Depression

Cited by 65

Actigraphic Measurement of Motor Deficits in Acute Ischemic Stroke

Gebruers, N., Truijen, S., Engelborghs, S., Nagels, G., Brouns, R., & De Deyn, P. P. (2008) · Cerebrovascular Diseases

Stroke Rehabilitation and RecoveryAcute Ischemic Stroke Management

Cited by 61

Agitation-associated behavioral symptoms in mild cognitive impairment and Alzheimer's dementia

Van der Mussele, S., Le Bastard, N., Saerens, J., Somers, N., Mariën, P., Goeman, J., De Deyn, P. P., & Engelborghs, S. (2015) · Aging & Mental Health

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 60

No correlation between time‐linked plasma and CSF Aβ levels

Le Bastard, N., Aerts, L., Leurs, J., Blomme, W., De Deyn, P. P., & Engelborghs, S. (2009) · Neurochemistry International

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 59

Behavioral correlates of cerebrospinal fluid amino acid and biogenic amine neurotransmitter alterations in dementia

Vermeiren, Y., Le Bastard, N., Van Hemelrijck, A., Drinkenburg, W. H., Engelborghs, S., & De Deyn, P. P. (2013) · Alzheimer's & Dementia

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 56

Neuropsychiatric Symptoms in Mild Cognitive Impairment and Dementia Due to AD: Relation With Disease Stage and Cognitive Deficits

Wiels, W. A., Wittens, M. M. J., Zeeuws, D., Baeken, C., & Engelborghs, S. (2021) · Frontiers in Psychiatry

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 52

Genome-Wide Association Study of Alzheimer’s Disease Brain Imaging Biomarkers and Neuropsychological Phenotypes in the European Medical Information Framework for Alzheimer’s Disease Multimodal Biomarker Discovery Dataset

Homann, J., Osburg, T., Ohlei, O., Dobricic, V., Deecke, L., Bos, I., Vandenberghe, R., Gabel, S., Scheltens, P., Teunissen, C. E., et al. (2022) · Frontiers in Aging Neuroscience

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 46

Validation of microRNAs in Cerebrospinal Fluid as Biomarkers for Different Forms of Dementia in a Multicenter Study

Müller, M., Kuiperij, H. B., Versleijen, A. A. M., Chiasserini, D., Farotti, L., Baschieri, F., Parnetti, L., Struyfs, H., De Roeck, N., Luyckx, J., et al. (2016) · Journal of Alzheimer’s Disease

MicroRNA in disease regulationDementia and Cognitive Impairment Research

Cited by 41

Validation of a quantitative cerebrospinal fluid alpha-synuclein assay in a European-wide interlaboratory study

Kruse, N., Persson, S., Alcolea, D., Bahl, J. M. C., Baldeiras, I., Capello, E., Chiasserini, D., Bocchio Chiavetto, L., Emersic, A., Engelborghs, S., et al. (2015) · Neurobiology of Aging

Parkinson's Disease Mechanisms and TreatmentsClinical Laboratory Practices and Quality Control

Cited by 38

Meta-analysis of genetic association with diagnosed Alzheimer’s disease identifies novel risk loci and implicates Abeta, Tau, immunity and lipid processing

Kunkle, B., Grenier-Boley, B., Sims, R., Bis, J., Naj, A., Boland, A., Vronskaya, M., van der Lee, S., Amlie-Wolf, A., Bellenguez, C., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory)

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 35

Neurogranin as biomarker in CSF is non-specific to Alzheimer's disease dementia

Willemse, E. A. J., Sieben, A., Somers, C., Vermeiren, Y., De Roeck, N., Timmers, M., Van Broeckhoven, C., De Vil, B., Cras, P., De Deyn, P. P., et al. (2021) · Neurobiology of Aging

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 34

The Use of Biomarkers and Genetic Screening to Diagnose Frontotemporal Dementia: Evidence and Clinical Implications

Gossye, H., Van Broeckhoven, C., & Engelborghs, S. (2019) · Frontiers in Neuroscience

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 34

Predictive value of upper-limb accelerometry in acute stroke with hemiparesis

Gebruers, N., Truijen, S., Engelborghs, S., & De Deyn, P. P. (2013) · Journal of Rehabilitation Research and Development

Stroke Rehabilitation and RecoveryAcute Ischemic Stroke Management

Cited by 24

Added diagnostic value of cerebrospinal fluid biomarkers for differential dementia diagnosis in an autopsy-confirmed cohort

Niemantsverdriet, E., Feyen, B. F. E., Le Bastard, N., Martin, J.-J., Goeman, J., De Deyn, P. P., Bjerke, M., & Engelborghs, S. (2018) · Journal of Alzheimer s Disease

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 19

Investigation of the role of matrix metalloproteinases in the genetic etiology of Alzheimer's disease

Hoogmartens, J., Hens, E., Engelborghs, S., De Deyn, P. P., van der Zee, J., Van Broeckhoven, C., & Cacace, R. (2021) · Neurobiology of Aging

Alzheimer's disease research and treatmentsProtease and Inhibitor Mechanisms

Cited by 17

Multiomics machine learning identifies inflammation molecular pathways in prodromal Alzheimer’s Disease

Gómez-Pascual, A., Naccache, T., Xu, J., Hooshmand, K., Wretlind, A., Gabrielli, M., Lombardo, M. T., Shi, L., Buckley, N. J., Tijms, B. M., et al. (2023) · medRxiv

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 1